Difference between revisions of "Eluvixtamab (AMG-330)"
Jump to navigation
Jump to search
m |
Warner-admin (talk | contribs) m (Text replacement - "Category:Drug index" to "Category:Drugs") |
||
| Line 2: | Line 2: | ||
Bispecific T-cell engager (BiTE) antibody that engages CD33 and CD3 | Bispecific T-cell engager (BiTE) antibody that engages CD33 and CD3 | ||
| − | [[Category: | + | [[Category:Drugs]] |
[[Category:Chemotherapy]] | [[Category:Chemotherapy]] | ||
[[Category:Immunotherapy]] | [[Category:Immunotherapy]] | ||
Revision as of 22:20, 13 June 2018
Mechanism of action
Bispecific T-cell engager (BiTE) antibody that engages CD33 and CD3